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ABSTRACT

Mulan is an E3 ubiquitin ligase embedded in the outer mitochondria membrane. Mulan’s
participation in the ubiquitination process is conducted through its cytosol-exposed RING finger
domain, and its ability to modulate protein ubiquitination makes it a key player in mitochondrial
and cellular homeostasis. Mulan is known to be involved in mitochondrial fission, fusion,
mitochondrial stress, apoptosis, and Parkin-independent mitophagy. Dysregulation of Mulan in
mice has been shown to correlate with human neurodegenerative disorders and heart disease.
Accumulation of Mulan is predicted to be responsible for the motor neuron degeneration 2
(mnd2) phenotype in mutant mice through the deregulation of the Mulan-dependent pathway of
mitophagy. The purpose of this study was to utilize both a yeast two-hybrid screen as well as an
in vitro profiling assay to characterize interactions between Mulan and potential E2 conjugating
enzymes. Through these studies, Ube2D1, Ube2D2, and Ube2D3 were identified as strong
interactors with the Mulan-RING domain. The tissue specific expression and protein levels of
these E2 conjugating enzymes was further investigated in mouse tissues by SDS-PAGE and
Western blot analysis. They all had similar patterns of expression and were present in brain,
heart, kidney, and liver tissues, with the highest level seen in the brain. This data demonstrates
that Mulan has a primary function in the brain and it suggests that Mulan’s deregulation might be
involved in the development and progression of neurodegeneration.
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CHAPTER 1: INTRODUCTION AND REVIEW OF LITERATURE

Mitochondria ubiquitin ligase activator of NF-κB (Mulan), also coined Mitochondriaanchored protein ligase (MAPL), growth inhibition death E3 ligase (GIDE), Hades,
Mitochondrial ubiquitin protein ligase 1 (Mul1), C1orf166, and RNF218, is one of three E3
ubiquitin ligases located within the outer mitochondrial membrane (OMM) [1-5]. Mulan is a
352-amino acid protein with a molecular weight of 39.8 kDa. The protein includes two
transmembrane domains (TMDs) and it is orientated in the OMM such that both the N- and Ctermini face the cytosol, leaving a large BAM (beside a membrane) / GIDE domain within the
intermembrane space (IMS) (Figure 1) [6]. The C-terminus includes a RING finger domain, the
key component for Mulan’s E3 ligase activity and a major regulator of cellular and
mitochondrial dynamics. An intact RING finger (amino acids 259-352) and proper localization
to the mitochondria is required for Mulan’s participation in cell growth, mitophagy,
mitochondrial fission/fusion, apoptosis and vesicle transport [1]. The BAM-RING regions are
highly conserved, supported through phylogenetic analysis that determined Mulan to be present
with the origin of holozoan and viridiplantae lineages [6]. Mulan is expressed ubiquitously with
the highest expression in the heart, placenta, liver, kidney, and brain [1].
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A.

B.

Figure 1: Mulan E3 ubiquitin ligase location and domains

A. Schematic diagram indicating the three mitochondrial E3 ubiquitin ligases and their
topology on the OMM.
B. Mulan is a 352-residue protein, and includes two TMDs, a BAM/GIDE domain within
the IMS, and the RING finger domain facing the cytosol. The RING finger domain is
responsible for the ligase activity of the protein.
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1.1 The Ubiquitin-Proteasome System

Mulan’s main molecular function is as an E3 ubiquitin ligase in the ubiquitination
process. Ubiquitination is a cytosolic system of targeted protein degradation that uses ubiquitin
(Ub) and a three-enzyme cascade. Ub is a small molecule (76 amino acids) that is covalently
attached as a post-translational modification to a substrate [7]. Attachment occurs at the amino
terminus or at internal lysine residues of the substrate by Ub’s C-terminal Gly76. Multiple
rounds of ubiquitination result in a polyubiquitin (polyUb) tag, Ub molecules attaching to each
other at one of seven internal lysine residues, with the Lys48 and Lys63 sites being the most
frequently polyubiquitinated. Lys48 polyUb has been associated with degradation by the 26S
proteasome [8]. PolyUb shuttles include a Ub-associating domain to bind to the Ub, a Ub-like
domain to target the complex to the proteasome, and innate abilities to protect the polyUb tag
from deubiquitinating enzymes (DUBs), the modulators for the reverse process [7].
Ubiquitination occurs in a series of three steps with enzymes E1, E2, and E3: (1) E1
activates ubiquitin, (2) E2 conjugates ubiquitin to a carrier, and (3) E3 ligates Ub to the substrate
target (Figure 2). The human genome encodes 2 E1s, about 50 E2s, and approximately 700 E3s
[9]. The two most common classes of E3 ubiquitin ligases include: RING finger proteins and
HECT domain enzymes. For the RING finger E3 proteins, there is a complex formed between
the E2, E3, and substrate for the Ub transfer, whereas HECT domains include a Ub-thiolesterintermediate before transfer [7]. Mulan, as an E3 ubiquitin ligase of the RING finger protein
class, participates in the direct translocation of the activated Ub from an E2 conjugating enzyme
to the substrate, which often targets the substrate for degradation by the 26S proteasome.
3

SUMOylation is a similar process to ubiquitination that adds SUMO molecules onto
targets as a post-translation modification. SUMO is a ubiquitin-like modifier that, when added,
aids in a variety of cellular processes including localization, signaling, and maintenance of other
post-translational modifications. SUMOylation also involves a three-enzyme cascade: (1) E1
heterodimer, (2) E2 ligase Ubc9, and (3) and E3 ligase. Mulan has been reported to also function
as an E3 SUMOylation ligase [10].
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Figure 2: The Ubiquitination process and Mulan E3 ubiquitin ligase

Ubiquitination is a process that involves three different steps with three different enzymes: an E1
ubiquitin activator, an E2 conjugating enzyme, and an E3 ligating enzyme. Mulan is an E3
ligating enzyme, responsible for tagging Ub molecules to substrates transferred from an E2. This
transfer requires formation of a complex between E2, E3, and the substrate.
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1.2 Mitochondrial Dynamics

Mulan’s function has also been implicated in mitochondrial fusion, fission, apoptosis, and
mitochondrial vesicle transport [1-3,10].
Mitochondria are constantly adjusting their size, shape, and location, and together they
exist in a coordinated network. These changes result from mitochondrial fusion (the combining
of two mitochondria into one) and fission (the splitting of one mitochondrion into two) (Figure
3). Fusion is controlled by mitofusin 1 and 2 (Mfn1 and Mfn2): the proteins are tethered to the
OMM and their cytosolic component contains a GTPase responsible for binding an adjacent
mitochondrion; OPA1, a dynamin-like GTPase located within the IMS or IMM, is responsible
for IMM fusion and the regulation of cristae morphology [11]. Mulan ubiquitinates Mfn2 and
targets it for degradation [5].
Mitochondrial fission is controlled by the GTPase Dynamin-related protein 1 (Drp1). An
increase in Drp1 leads to an increase in fission. This protein is a substrate for Mulan’s E3
SUMOylation activity. During induction of apoptosis, Mulan SUMOylates Drp1, which results
in stabilization of a mitochondria-endoplasmic reticulum complex that permits calcium flux. In
turn, this leads to cristae remodeling, and cytochrome c release, which activates the caspase
dependent pathway of apoptosis [12].
Overall, Mulan stabilization of Drp1 by SUMOylation and breakdown of Mfn2 by
ubiquitination enhances fission and impedes fusion [13]. Mulan knockdown with siRNA has also
been shown to result in mitochondrial perinuclear clustering, whereas Mulan accumulation has
been shown to result in mitochondrial fragmentation [1,7].
6

Apoptosis is a process of cell death and it can occur due to many forms of cellular stress,
including OMM depolarization. Mulan is involved in apoptosis by ubiquitinating the tumor
suppressor p53 and p73 proteins [4,14], as well as Akt, an antiapoptotic protein [15,16]. In
addition, Mulan activates the protein kinase JNK just before the apoptosis associated caspase
cascade is initiated [3]. In contrast, activation of the NF-κB transcription factor by Mulan during
conditions of ER stress leads to the production of several antiapoptotic factors [17]. Therefore,
Mulan’s placement in apoptosis often appears contradictory and the dynamics are still not highly
understood.
Lastly, one of Mulan’s initial functions was defined by its presence in mitochondrialderived vesicles (MDV) that fuse with peroxisomes. However, most peroxisomes do not contain
Mulan, and only about 5-15 MDVs contain Mulan per cell. Vesicles that possess Drp1 were also
found to block Mulan’s ability to cause mitochondria fragmentation and resulted in increased
interconnectedness of the endoplasmic reticulum [2]. An interactor of Mulan, Vps35, is involved
in Mulan-MDV formation and transport of Mulan to the peroxisome [18]. Vps35 deficiency
leads to an increase in Mulan expression and mitochondrial fragmentation. Vps35 mutation is
linked to familial PD [19].
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Figure 3: Mitochondrial fission and fusion

Mitochondria alternate their shape and size through the processes of fission and fusion in order
to maintain health and manage damage. Fission is the splitting of one mitochondrion into two
and involves the Drp1protein. Fusion is the combining of two mitochondria to form one and
involves the Mfn1, Mfn2, and OPA1 proteins. Damaged mitochondria exit the cycle through
mitophagy.
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1.3 Mitophagy

Autophagy is the process of cytoplasmic sequestering within an autophagosome and the
subsequent degradation by the merging with a lysosome. Nutrient deprivation, starvation, or
hormone release can result in autophagy for the salvaging of precursor metabolites, however,
autophagy is a continuous process that requires no stress for baseline functioning [20].
Autophagosomes are double-membraned vesicles that work to isolate damaged or excess cellular
material. The overall process of autophagy includes induction, formation of the autophagosome,
fusion of the autophagosome with a lysosome, breakdown of the cellular components with the
lysosome’s hydrolytic enzymes and release of the products into the cytosol [21].
Mitophagy is a form of autophagy that specifically targets mitochondria for degradation
and is responsible for maintaining a healthy mitochondrial population. The term “mitophagy”
was coined to emphasize the selective and non-random nature of mitochondrial destruction [20].
Mitochondria may become damaged or dysfunctional, for example, through dysregulation of
fission/fusion, through age, through mitochondrial permeability transition (MPT), or through an
accumulation of reactive oxygen species (ROS) such as hydrogen peroxide, superoxide, and
hydroxyl radical, the byproducts of oxidative phosphorylation in aerobic metabolism that cause
mutation [7,20,21]. The ROS result in a depolarization of the mitochondrial membrane potential,
an event that forces the signaling for autophagosome engulfment and mitophagy. Even in nonproliferating tissues, mitochondria are still replaced every 10-25 days through the binary fission
of pre-existing mitochondria to generate the new and mitophagy to destroy the old [20].
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Mitophagy was first associated with PINK1 and Parkin, proteins whose gene mutations
are linked to Parkinson’s Disease (PD). PINK1 is a mitochondrial targeted serine-threonine
kinase and Parkin is an E3 ubiquitin ligase in the cytosol [5, 22, 23]. In healthy mitochondria
with high membrane potential, PINK1 is imported into the mitochondria and degraded. When a
mitochondrion is damaged, and the membrane potential is lowered, the import of PINK1 is
inhibited and it accumulates on the OMM. PINK1 phosphorylates Ub and Mfn2, which then
recruits Parkin. Binding of Parkin to the phospho-ubiquitin chain and further phosphorylation of
Parkin by PINK1 directly leads to activation of Parkin’s ubiquitin ligase activity for OMM
substrates. Extensive ubiquitination of OMM proteins leads to mitophagy. Parkin ubiquitinates
p62, which binds LC3 and leads to autophagosome formation [24] (Figure 4).
Studies on Drosophila indicate that downregulation of Mfn2, mitochondrial fusion
promoting, and upregulation of Drp1, mitochondrial fission promoting, results in the suppression
of PD phenotype when PINK1 or Parkin are absent [22]. Mitophagy can be induced in vitro with
the mitochondrial uncoupler carbonyl cyanide m-chlorophenyl hydrazine (CCCP) for study
purposes [23].
The role of Parkin as a universal inducer of mitophagy has recently been challenged [5].
Parkin expression is restrictive and inactivation of the protein in mice produces no discernible
phenotype [25]. Recent work from our lab as well as others suggest that Mulan is involved in a
mitophagy pathway that is independent of Parkin [26]. Studies have also suggested that Mulan is
capable of compensating for the loss of PINK1/Parkin and that expression of wild-type Mulan
can suppress the PD phenotype when PINK1/Parkin are mutated or when Mfn2 is overexpressed.
Additionally, fly mutants have shown that the removal of Mulan in PINK1/Parkin mutants
10

results in aggravated PD phenotype and double knockouts (PINK1/Mulan or Parkin/Mulan)
result in further muscle degeneration and potential lethality. Mouse cortical neurons with Parkin
KO or Mulan KD (knock down) have shown decreased mitochondrial membrane potential.
Interaction between Mulan and PINK1/Parkin is thought to not be direct, but exist
through Mfn2: analysis of HeLa cells show stabilization of Mfn2 when Mulan is not present
(Parkin is not expressed in HeLa cells and does not confound) [5].
Mulan has also been found to be directly regulated by the mitochondrial Omi/HtrA2. Omi
is a serine protease that normally resides in the IMS, exhibiting a role in mitochondrial
homeostasis with protein quality control. Additionally, Omi is released into the cytosol and
participates in apoptosis during stress. Inactivation of Omi’s protease ability by a single mutation
(S276C) leads to the mnd2 (motor neuron degeneration 2) phenotype in mutant mice, exhibiting
neurodegeneration, premature aging, muscle wasting, and parkinsonian features [26].
We have previously found that Mulan is a substrate of Omi and that mnd2 mutant mice
show an accumulation of Mulan in their tissues. It is thought that Mulan’s increase results in
mitochondrial dysfunction that mirrors mitochondrial uncoupling and leads to mitophagy.
Imbalance in mitochondria numbers may result in energy deficiency for high-energy consuming
cells, including muscle cells, neurons, and cardiomyocytes, leading to the observed mnd2
phenotype. Omi interacts with a domain of Mulan that is similar in residue sequence to a known
substrate of Omi, Inhibitor of Apoptosis Proteins [26]. Omi is thought to be phosphorylated by
PINK1 before interacting with Mulan (24).
Further support of Mulan’s role in mitophagy comes from studies where Mulan was
shown to ubiquitinate ULK1 in the regulation of selenite-induced mitophagy [27].
11

Figure 4: PINK1 and Parkin mechanism in damaged mitochondrial removal

In healthy mitochondria, the kinase PINK1 is transported into the OMM and IMM by TOM and
TIM, respectively. Normal degradation then occurs with PARL and MPP. In damaged
mitochondria, PINK1 becomes trapped inside TOM, and phosphorylates Mfn2, which attracts
Parkin E3 ubiquitin ligase to the mitochondria for phosphorylation. Parkin then ubiquitinates
many mitochondrial proteins, including p62, which binds LC3 and initiates autophagosome
formation.
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1.4 Mulan E2 Interactors

Mulan is an E3 ubiquitin ligase and as such it will interact with specific E2 conjugating
enzymes in order to carry out its function. Our lab recently identified four specific E2
conjugating enzymes as specific interactors of Mulan in a yeast two-hybrid screen of a HeLa
cDNA library. These enzymes are: Ube2E2, Ube2E3, Ube2G2, and Ube2L3. In addition, a
modified yeast two-hybrid screen was used where Mulan’s RING domain was fused to each of
the E2s to isolate potential substrates for the Mulan259-352-E2 complex. GABARAP was isolated
as a key interactor for the Mulan259-352-Ube2E3 fusion protein; this protein is a member of the
Atg8 family and participates in mitophagy, a potential link in subsequently explaining Mulan’s
participation in mitophagy [28]
An alternative approach was recently used in our lab where recombinant Mulan-RING
protein was tested directly against most of the common E2s in an in vitro ubiquitination assay.
This was done to verify our yeast two-hybrid system results and to overcome a potential problem
that not all E2s might be present in the HeLa cDNA library. The profiling assay identified
Ube2D1, Ube2D2, Ube2D3, and Ube2E3 as very likely partner conjugating enzymes for Mulan
(Figure 9).
By studying Mulan’s E2 interactors, we hope to gain further insight into a pathway by
which Mulan E3 ubiquitin ligase regulates mitophagy and cell death following mitochondrial
stress, and how the inactivation of this pathway may be responsible for mnd2 phenotype in mice.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Overview of the Yeast Two-Hybrid System

The yeast two-hybrid system was used to verify and confirm protein-protein interactions
between Mulan’s RING domain and its anticipated E2 interactors: Ube2D1, Ube2D2, and
Ube2D3. Ube2E3 acted as a positive control. In the yeast two-hybrid (Figure 5), the protein of
interest and its potential interactor are separately cloned into different plasmid vectors, the
plasmids are transformed into yeast, expression is induced, and the produced proteins may
interact with each other and with an already present yeast plasmid to produce a color change
[29].
The protein of interest, Mulan259-352, is fused to a LexA DNA binding domain (BD) and
cloned into a pGilda vector. This is known as the bait. The LexA DNA binding domain
component oversees the locating and binding of the bait to the Upstream Activation Sequence
(UAS) for the lacZ reporter gene located on the pSH18-34 yeast plasmid. A collection of
potential protein interactors from a HeLa cDNA library are then fused with an activation domain
(AD) and cloned into a pJG4-5 vector. These are known as the prey. If the bait interacts with an
unknown prey, then the binding domain and the activation domain will be in close enough
proximity to create the full, functional transcription factor at the UAS (the complex: UAS-BDBait-Prey-AD). This leads to the transcription of the lacZ reporter gene for the synthesis of betagalactosidase and leucine (Figure 5). The gene for leucine is not located on the pSH18-34
plasmid, however, its transcription is managed at the same promoter, providing a check that the
proper plasmid is present and functioning [29].
14

In the presence of X-gal and galactose, the beta-galactosidase cleaves X-gal and a blue
color is produced. This positive interaction must be further tested to determine if it is a true
interaction between the proteins.
This yeast two-hybrid was abridged since the Ube2D prey were already isolated. A
complete scan of the library was unnecessary as we were looking specifically for interactions
implied in the in vitro profiling assay for Mulan. Second, Mulan259-352 was previously cloned into
pGilda and transformed into EGY48 yeast for past experiments, and this stock was used.

15

Figure 5: Schematic diagram of the yeast two-hybrid system

The bait consists of Mulan259-352 fused to a LexA-DNA binding domain and it is expressed in yeast.
The prey is the full length E2 protein fused to the Activation domain (AD). If the prey interacts
with the bait, it will activate transcription of the reporter gene (usually -galactosidase) and yeast
will turn blue
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2.2 Construction of pJG4-5-Ube2D Prey

2.2.1 Polymerase Chain Reaction
Prey Primer Construction:
Ube2D1: 5’ (EcoR1) – 5’ GGC GAA TTC ATG GCG CTG AAG AGG ATT CAG 3’
3’ (Xho1) – 5’ CCG CTC GAG TTA CAT TGC ATA TTT CTG AGT CCA 3’

Ube2D2: 5’ (EcoR1) – 5’ GGC GAA TTC ATG GCT CTG AAG AGA ATC CAC 3’
3’ (Xho1) – 5’ CCG CTC GAG TTA CAT CGC ATA CTT CTG AGT 3’

Ube2D3: 5’ (EcoR1) – 5’ GGC GAA TTC ATG GCG CTG AAA CGG ATT AAT AAG G 3’
3’ (Xho1) – 5’ CCG CTC GAG TCA CAT GGC ATA CCT CTG AGT CCA 3’

DNA for Ube2D1, Ube2D2, and Ube2D3 was amplified with the preceding primers at
EcoR1 and Xho1 restriction enzyme sites. The PCR mix included: 1 µl of DNA Template, 100
µM of Forward Primer (eurofins), 100 µM of Reverse Primer (eurofins), 1 µl of dNTPs
(Clontech), 5 µl of (10x) PCR Running Buffer (NEB), 40.8 µl of sterile water, and 0.2 µl of
TAQ Polymerase (Roche Diagnostics Corp). The thermocycler abided by the following: 2
minutes of template denaturing at 95 ⁰ C, 29 cycles, and a final elongation period of 7 minutes at
72 ⁰ C. Each cycle consisted of denaturing at 95 ⁰ C for 30 seconds, primer annealing at 56 ⁰ C
for 30 seconds, and TAQ Elongation at 72 ⁰ C for 35 seconds. Samples were kept on ice.
Template DNA for Ube2D2 was taken from a HeLa library.
17

2.2.2 Agarose Gel Electrophoresis
Gels were prepared by adding 1.5 g of agarose powder (Promega) to 100 ml of (1x) TAE
DNA Running Buffer. Microwaving for 2 minutes with intermittent solution swirling permitted
the agarose to dissolve. 5 µl of ethidium bromide, the UV-associated viewing agent, was added
while the solution was warm. Solution was then poured into a gel casket with two combs. Gel
was left to solidify during the cooling process. After cooling, the combs were removed, and the
gel was cut to give the appropriate quantity of wells. TAE buffer was poured over the gel, filling
the casket, until the gel was fully immersed. Sample preparation included combining 2 µl of PCR
DNA with 5 µl of DNA dye. The GeneRuler 1 kb plus DNA ladder (ThermoFisher) of multiple
known DNA sizes was pipetted into the first well, and then each of the samples were added.
Viewed with a gel doc, ethidium bromide fluorescence indicated the location and comparative
size of DNA samples.

2.2.3 Precipitation
PCR product was precipitated to remove residual salts from the PCR buffer solution and
to further purify the amplified DNA. Sample volume was brought up to 100 µl with water. 10 µl
of sodium acetate (10% of sample volume) and 200 µl of (100%) ethanol (2x the sample
volume) were added. Tubes were inverted several times and stored at -20 ⁰ C for 30 minutes.
Next, tubes were spun at 13,200 rpm for 20 minutes within a 4 ⁰ C fridge. Supernatant was
removed, pellet was dried in a speed vacuum for 15 minutes, and re-suspended in 50 µl of water.
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2.2.4 Restriction Enzyme Digestion
5 µl of precipitated DNA (Ube2D1, Ube2D2, and Ube2D3 inserts, and stock pJG4-5
vector), 5 µl of (10x) Restriction Enzyme Buffer (NEB), 0.5 µl of (100x) BSA (NEB), 41.5 µl of
dH2O, and 1 µl of restriction enzyme were combined and incubated in a 37 ⁰ C water bath. After
an hour, 0.5 µl more enzyme was added, and incubation continued for another hour. This was
performed first using Xho1 restriction enzyme, and then separately conducted using EcoR1
restriction enzyme, each with their appropriate buffer. Next, the insert DNA was precipitated,
and the 4-5 vector DNA was ran on a 1.5% agarose gel, extracted and purified according to the
methods in the Gel DNA Recovery Kit (Zymoclean). 50 µl of dH2O was added to the samples to
bring the volume up to 100 µl. Samples were precipitated.

2.2.5 Ligation
2 µL of digested DNA was run on a 1.5% agarose gel and the quantity of DNA within 1
µl of insert and 1 µl of 4-5 vector was estimated. DNA used for ligation should be 3:1 for the
vector to insert ratio. Each sample received 4 µl of vector, varied insert DNA (7 µl Ube2D1, 7 µl
Ube2D2, 5 µl Ube2D3, 0 µl (Negative control), 3 µl of (5x) buffer, 1 µl of ligase, and enough
dH2O to bring each sample up to 15 µl. Samples were incubated at room temperature for 20
minutes. 35 µl of dH2O was added to bring the samples up to 50 µl. Desalting occurred with the
addition of 500 µl of (10x) butanol. Tubes were inverted several times and spun at 13,200 rpm
for 15 minutes. Butanol was removed by pipette and tubes were dried for 15 minutes in a speed
vacuum. Pellet was resuspended in 10 µl of dH20.
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2.2.6 Bacterial Transformation
Electrocompetent bacteria cells (Dh5α) were retrieved from a -80 ⁰ C freezer and thawed
slowly on ice. Electroporation cuvettes were also chilled. 3 µL of ligated DNA was added to the
tube of thawed bacteria cells (50 µL) and the entire solution was transferred to its respective
cuvette. The Gene Pulser (Bio Rad) was set to 2.5 kV at 400 Ω. After electroporation, 800 µL of
LB was quickly added to each cuvette, mixed, and transferred to a fresh tube. Samples were
incubated by rotator for 1 hour at 37 ⁰ C. 250 µL of each sample was then plated on LB + AMP
plates, with plastic beads (Fisher) to spread, and left to incubate over-night (O/N). Grown
colonies were selected the following day and added to 1.5 ml of LB + AMP broth. Tubes were
also incubated O/N.

2.2.7 Isolation of Plasmid from Bacteria: DNA-Boiling Miniprep
Cells and media were transferred into 1.5 mL Eppendorf tubes and spun at 13,200 rpm
for 2 minutes at room temperature (RT). The supernatant was removed by aspiration and the
pellet was resuspended in 300 µL of STET-lysozyme solution (8% sucrose, 5% (100X) Triton,
50 mM Tris-HCl pH 8, 50 nM of EDTA, 10 mg/mL of lysozyme). Samples were then boiled for
1 minute and spun at 13,200 rmp for 10 minutes. Mucus pellets were removed with a toothpick.
200 µL of (70%) isopropanol was added, and tubes were mixed by inverting. Samples were spun
again at 13,200 rpm for 10 minutes. Isopropanol was removed by pouring out the supernatant in
one motion. 200µL of (70%) ethanol was added with no mixing. Samples were spun at 13,200
rpm for 5 minutes. Ethanol was also removed by pouring out the supernatant in one motion and
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the tubes were dried in a speed vacuum for 15 minutes. Pellets were resuspended in 100 µL of
Tris-EDTA (TE) and vortexed using a Fisher Vortex Genie 2 for 10 minutes.

2.2.8 Isolation of Plasmid from Bacteria: DNA QIAprep Spin Miniprep
The methods suggested within the QIAprep Spin Miniprep Kit (QIAgen) were used.
Bacteria grown O/N was spun at 11,2000 rpm for 2 minutes. Supernatant was aspirated out and
the pellet was resuspended in 200 µL of Buffer P1, which contains lysozyme and RNAse. Then,
200 µL of Buffer P2 was added, which contains SDS, tubes were inverted to mix and left at RT
for 5 minutes. 250 µL of Buffer N3 was added, the tubes were inverted to mix, and spun at
11,2000 rpm for 10 minutes. Supernatant was loaded into a QIAprep spin column and
centrifuged for 1 minute. The flow through was discarded, the column was washed with 600 µL
of Buffer PB, and tubes were centrifuged for 3 minutes. A subsequent wash occurred. The
column was spun for 1 more minute to dry. Finally, the QIAprep spin column was placed in a
fresh 1.5mL Eppendorf tube and the column was eluted with 50µL of Buffer EB (10 mM Tris-Cl
pH 8.5) before a final centrifugation for 1 minute.

2.2.9 Restriction Enzyme Double Digestion
To test which DNA samples contained a successfully transformed plasmid-insert
combination, a double digestion with EcoR1 and Xho1 was performed. A master mix was
prepared and equally distributed to a fresh 50 µL Eppendorf tube per sample. Each sample
contained: 11.4 µL of dH2O, 2 µL of (10X) Restriction Enzyme Buffer (NEB), 0.2 µL (100X)
BSA (NEB), 0.2 µL of EcoR1, and 0.2 µL of Xho1. 6 µL of DNA brought each sample up to 20
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µL. All samples were incubated at 37 ⁰ C for 2 hours. 2 µL of each digested sample was then run
on an agarose gel with RNAse loading dye and tested by visualization to determine insert
presence. Clean DNA samples from the mini prep that contained the desired insert were stored at
20 ⁰ C.
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2.3 The Yeast Two-Hybrid

2.3.1 Yeast Drop-Out Medium
Yeast drop-out powder (Sigma) consists of all 20 amino acids except the amino acids
desired for drop-out mediums. The yeast two-hybrid plasmids associated with this study have
selectable markers that permit them the ability to self-produce certain amino acids; a colony’s
presence in drop-out medium specific to an amino acid the plasmid can produce, therefore,
indicates the plasmid’s presence within the colony. To distinguish yeast pSH18-34 plasmid,
uracil (U-) is left out from the medium (Figure 6). To distinguish the presence of pGilda after
transformation, histidine (H-) is left out (Figure 7), and to distinguish the presence of pJG4-5
after transformation, tryptophan (W-) is left out (Figure 8). Expression for all of the vectors are
under the GAL1 promoter and can be induced in the presence of galactose and repressed in the
presence of glucose.
Yeast drop-out medium consisted of the following: 1 g dropout powder (Sigma), 3.35 g
Yeast Nitrogen Base (Sigma), 10 g glucose or 10 g galactose and 5 g raffinose dissolved in dH2O
to a volume of 500 ml, and 10 g agar (Apex) if the medium was for plates. Solution was
autoclaved for 40 minutes and cooled before the addition of 50 ml (10X) BU salt and 1 ml X-Gal
if the medium was for blue-white screening. Media with agar was poured into plates, left to
solidify, and stored at 4 ⁰ C, while bottled non-agar media was left at room temperature.
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Figure 6: EGY48 yeast pSH18-34 vector

A LacZ reporter plasmid present in the EGY48 yeast strain and replicated with the 2 µm origin.
Expression of LacZ is controlled by 8 LexA operators with the GAL1 promoter. Additionally,
URA3 serves as a selectable marker and the ampR enables ampicillin resistance.
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Figure 7: pGilda vector used for Mulan259-352 bait cloning

A cloning vector that fuses the bait protein of interest with LexA, which acts as the DNA binding
domain. The ARS/CEN ori is used to replicate in yeast using the GAL1 promoter. HIS3 serves as
the selectable marker and ampR is present for ampicillin resistance. Cloning utilizes the EcoR1
and Xho1 restriction sites.
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Figure 8: pJG4-5 vector used for Ube2D prey cloning

A cloning vector that fuses the prey proteins with B42, which acts as the DNA Activating
Domain. The 2 µm ori is used to replicate in yeast using the GAL1 promoter. TRP1 serves as the
selectable marker and ampR is present for ampicillin resistance. Cloning utilizes the EcoR1 and
Xho1 restriction sites. Additionally, this vector includes a nuclear localization sequence (NLS)
and a hemagglutinin (HA) epitope tag.
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2.3.2 Yeast Transformation
50
ml U- H- glucose medium was inoculated with a single EGY48 yeast colony and grown shaking
O/N at 30 ⁰ C; this colony was stock from previously transformed yeast with LexA-Mulan259-352
and, therefore, possessed not only the normal yeast plasmid pSH18-34, but also pGilda. Cells
were harvested at 38,000 rpm (Allegra 6R Centrifuge) for 5 minutes. The supernatant was
poured out and the cells were washed with 10 ml of TE pH 7.5 (10 mM Tris pH 5, 1 mM EDTA
pH 8). Cells were spun for 5 minutes and the TE was poured out. Cells were resuspended in 5 ml
LA (0.1 M LiAC in TE) and incubated shaking at 30 ⁰ C for 2 hours. Cells were spun at 3,000
rpm for 5 minutes and the LA was poured out. Cells were resuspended in 5 ml of LA. Salmon
sperm DNA (SS DNA) was boiled for 5 minutes. 300 µL aliquots of yeast + Mulan259-352 cells, 2
µL of denatured SS DNA , and 5 µl of clean (miniprep) prey DNA were combined for
transformation. 700 µL PEG (50% Peg 4000 in LA) (Sigma) was added to the solution, and
resuspended to mix. Incubation occurred in a 30 ⁰ C water bath for 30 minutes. Cells were heat
shocked for 15 minutes at 42 ⁰ C in a second water bath and collected by centrifugation at
13,200 rpm for 3 minutes. Supernatant was aspirated, and the pellet was resuspended in 300 µL
of TE pH 7.5. 100 µL of transformed yeast was plated on U- H- W- glucose plates and grown for
2 days. Grown colonies were selected the following day and added to 1.5 mL of U-H-W- glucose
media. Tubes were also incubated O/N.
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2.3.3 Yeast Induction
Cells and media were transferred into 1.5 ml Eppendorf tubes and centrifuged at 32,000
rpm for 3 minutes. Supernatant was poured out and 1 ml of U-H-W- galactose/raffinose media
was added to wash. After centrifugation for 3 minutes, the supernatant was aspirated out and 500
µL of fresh U-H-W- galactose/raffinose was added. Yeast was resuspended with vortexing. An
additional 1 ml of U-H-W- galactose/raffinose media was added to the Eppendorf tubes and 1 ml
of U-H-W- glucose media was added to the original incubation tubes. New and old tubes were
incubated for 4 hours at 30 ⁰ C. Cells and media were then transferred to fresh tubes, spun, and
the supernatant was removed. 100 µL of ESB (2% SDS, 80mM Tris pH 6.8, 10% glycerol, 1.5%
DTT, and 0.1 mg/ml bromophenol blue) was added to the yeast samples and to Ube2D1 and
Ube2E3 non-induced samples for control. Resuspension revealed blue coloring. Samples were
boiled for 5 minutes, vortexed thoroughly, boiled for an additional minute, and spun down to
collect. Samples were stored at -20 ⁰ C.

2.3.4 Yeast SDS PAGE and Western Blot
Induced and non-induced sample supernatant was analyzed using SDS PAGE with the
12% resolving and 5% stacking gels. Samples were prepared with the addition of 5 µL (4X)
sample buffer (10% β-mercaptoethanol, 6% SDS, 20% glycerol, 1/40 stacking buffer, and 0.2
mg/ml bromophenol blue) to 20 µl of supernatant and 1 minute of boiling. A western transfer
was performed using a PVDF membrane. The membrane was activated with 10 ml methanol, 10
ml (5X) TBS buffer and 30 ml dH2O before transfer. α-HA (Sigma) (binds to the prey-fusion
protein) mouse monoclonal primary antibody was diluted 1: 5,000 in 2% milk-TBST (250 mM
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Tris pH 8, 1.25 M NaCl, and 0.1% Tween20) and α-LexA-HRP (SC) (binds to the bait-fusion
protein) mouse monoclonal primary antibody was diluted 1: 500. After blocking with milk and
washing with TBST, the membrane was incubated O/N at 4 ⁰ C shaking with the appropriate
primary antibody. The membrane was washed, rabbit α-mouse, HRP conjugated secondary
antibody (Jackson ImmunoResearch) diluted 1: 10,000 was used for 1-hour incubation, and the
membrane was washed again. Protein visualization occurred using the chemiluminescence ECL
kit (PIERCE). Blue sensitive autoradiography film (MIDSCI) was used for development in a
SRX-101A (Konica).
12% resolving gels consisted of the following: 8 ml 40% acrylamide mix (BioRad), 10
ml dH2O, 6.3 ml 1.5 M Tris pH 8.8, 250µL 10% SDS, 250µL 10% APS, and 10µL TEMED
(Fisher). 5% stacking gels consisted of the following: 1.25 ml 40% acrylamide mix (BioRad), 7.3
ml of dH2O, 1.25 ml 1.0 M Tris pH 6.8, 100µL 10% SDS, 100µL 10% APS, and 10 µl TEMED
(Fisher).

2.3.5 Yeast Streaking and Spotting
Colonies from the yeast transformation were selected and streaked onto a U-H-W- glucose
plate. Colonies that grew on this master plate were used to streak a U-H-W- galactose / raffinose
plate. Results were photographed 2 days later.
The remaining protein-induced yeast was vortexed and transferred to a fresh 2 ml tube. 5
µl was used to spot a U-H-W- galactose / raffinose plate. Results were photographed the next day.
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2.4 Mouse Tissue Analysis

2.4.1 Mouse Tissue Preparation
Tissue from the brain, heart, liver, and kidneys were extracted from wild-type mice.
Homogenization was performed with an ULTRA TURRAX (IKA) for all samples besides the
brain, which was done by hand. A Bradford assay was performed to determine protein
concentration and quantity of each sample needed for the equalized loading of 20 µg. Sample
buffer was added, the samples were boiled for 1 minute, and they were briefly spun down to
collect. Samples were stored at -20 ⁰ C [30].

2.4.2 Mouse Tissue SDS PAGE and Western Blot
Techniques were performed as previously described. Primary monoclonal antibodies
included: rabbit α-Ube2D1 (Abcam), α-Ube2D2 (Abcam), α-Ube2D3 (Abcam), and α-Ube2E3
(Novus Biologicals) diluted 1: 5,000. Secondary antibodies included goat α-rabbit, HRP
conjugated (Jackson ImmunoResearch) diluted 1: 10,000. GAPDH was used as a loading control
in each gel.
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CHAPTER 3: RESULTS
3.1 Transformation and Screening of Mulan259-352 Interactors

Our lab’s previous yeast two-hybrid screen isolated both Ube2E2 and Ube2E3 as bona
fide interactors of Mulan259-352 [28]. The in vitro profiling assay identified these two, as well as
three additional E2s: Ube2D1, Ube2D2, and Ube2D3 (Figure 9).
To verify the validity of interaction for these proteins, Ube2D1, Ube2D2, and Ube2D3
were separately cloned in-frame into pJG4-5 vectors as described in Chapter 2. This yeast twohybrid was abridged since the Ube2D prey were already identified, making the HeLa library scan
unnecessary. Yeast cells pre-transformed with Mulan259-352 were transformed with the
synthesized prey and streaked onto U- H- W- glucose + X-gal plates and U- H- W- galactose /
reffinose + X-gal plates following induction. All three of the Ube2D prey showed an intense blue
color on the galactose / raffinose plates (Figure 10).
Ube2D1, Ube2D2, and Ube2D3 have approximate molecular weights of 11 kDa. The HA
tag and other proteins associated with the pJG4-5 vector have an estimated molecular weight of
about 14 kDa. Therefore, HA-Ube2D fusion proteins should have an approximate molecular
weight of 25 kDa (Figure 11).
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Figure 9: Results of the E2 selection and profiling assay for Mulan

An in vitro ubiquitination assay that uses recombinant His-Mulan259-352 with each of the indicated
E2 enzymes. Ube2D3, Ube2E3, Ube2D2, Ube2D1 conjugating enzymes were able to work
efficiently with Mulan259-352 in this assay. E2 proteins previously identified in our lab through the
yeast two-hybrid are boxed in red and new proteins are boxed in blue.
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Figure 10:Interaction of the various E2 enzymes with Mulan259-352 in yeast

Full length Ube2D1, Ube2D2, and Ube2D3 were cloned in-frame in the pJG4-5 vector and
transformed in yeast expressing LexA-Mulan259-352 bait. Ube2E3 was previously cloned and
characterized in our lab. Interaction between the bait and the different prey was tested on X-gal
plates. Blue color indicates a positive protein-protein interaction.
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Figure 11: Expression and stability of HA-E2 prey in yeast cells

Western blot analysis showing induced (i) and non-induced (ni) yeast expression for Ube2D
family members and Ube2E3. Primary antibody used was α-HA (Sigma). Lane 1: Induced 4-5
vector. Lane 2: Non-induced Ube2D1. Lane 3: Induced Ube2D1. Lane 4: Induced Ube2D2. Lane
5: Induced Ube2D3 Clone A. Lane 6: Induced Ube2D3 Clone B. Lane 7: Non-induced Ube2E3.
Lane 8: Induced Ube2E3.
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3.2 Tissue Specific Expression of Mulan259-352 Interactors

To investigate the expression of the various E2s in mouse tissues, brain, heart, kidney,
and liver tissue homogenates were prepared as described in Chapter 2 and analyzed by SDSPAGE and Western blotting. Antibodies used were monoclonal rabbit α-Ube2D1 (Abcam), αUbe2D2 (Abcam), α-Ube2D3 (Abcam), and α-Ube2E3 (Novus Biologicals).
Figure 12 shows that the expression and protein levels are very similar between all four
E2s in the mouse tissues tested. Highest expression is seen in the brain and lowest in the heart.
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Figure 12: Tissue specific expression and protein levels of various E2 partners of Mulan

Western blot analysis showing the expression of Ube2D1, Ube2D2, Ube2D3, and Ube2E3,
proteins in mouse tissues. GAPDH was used as a loading control.
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3.3 Characterization of Ube2D Interactors

There are four members of the Ube2D family, including Ube2D1, Ube2D2, Ube2D3, and
Ube2D4. Protein sequences among the three studied family members are high in homology.
NCBI BLAST indicates that Ube2D1 shares 89% identity with Ube2D2 and 88% identity with
Ube2D3. Ube2D2 and Ube2D3 share 97% identity (Figure 13). Since these proteins are all E2
conjugating enzymes, it follows that high homology should mark similar functioning in certain
areas.
Not much is known about the Ube2D family and their definitive roles in the cell,
however, the research has encompassed a variety of molecular processes. One of the first studies
described cadmium (Cd) exposure, a cause of renal dysfunction, decreasing Ube2D family
expression in rat renal tubular epithelial (NRK-52E) and human cells. It was hypothesized that
the inhibition of the Ube2D proteins enabled p53 accumulation and p53-dependent apoptosis
under Cd exposure [31]. Results varied for different cell types and pointed to an association of
Cd to renal toxicity, but not hepatic toxicity in mice. Human brain astrocytes (HBASTs)
uniquely showed Cd increasing Ube2D3 expression [32]. Inorganic arsenic also increased p53
expression, and it decreased expression in Ube2D1 and Ube2D2, but not in Ube2D3, within
NRK-52E cells. Inorganic mercury did not affect p53 or Ube2D protein levels. It was suggested
that arsenic, but not mercury, increased p53-dependent apoptosis through the suppression of
Ube2D proteins like Cd [33].
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Figure 13: Protein sequence alignment for Ube2D family members

Alignment for Ube2D1, Ube2D2, and Ube2D3 proteins shows high sequence homology.
Asterisks indicate sites of varied amino acid residues. Coloring corresponds to amino acid
properties.
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3.4 Characterization of Ube2D1

Ube2D1 has been shown to interact with the RING finger of two E3 ubiquitin ligases
besides Mulan. The herpes simplex virus, for example, requires the E3 ubiquitin ligase ICP0 for
proper initiation of the lytic cycle of infection and degradation of proteins involved in DNA
repair, centromere assembly, and antiviral proteins. The study pointed to Ube2D1 being a key
component to the system by which ICP0 initiates activation from viral quiescence [34]. Second,
Ube2D1 has been shown to interact with the E3 ubiquitin ligase March-I. Normal function for
March-I involves lowering the expression for MHC-II and CD86 proteins in antigen presenting
cells, proteins that mediate CD4 T cell activation. Ube2D1 is thought to aid in the ubiquitination
of March-I itself with an unknown E2, leading to March-I expression decrease and the
upregulation of MHC-II [35].
Lastly, Ube2D1 has been questioned for its potential influence in neurodevelopmental
processes that may be linked to schizophrenia; Ube2D1’s selection was based on its association
with the p53 pathway and its location at the chromosome region 10q21.1, which is adjacent to
the ANK3 gene, a likely schizophrenia relation found in previous single nucleotide
polymorphism (SNP) studies. SNPs in Ube2D1 for a case-control study did not correlate with
schizophrenia for this population, however, there was an observed reduction in the risk of cancer
for the patients over the decade study, surmised to be related to potential polymorphisms in p53
[36]. Ube2D1 continued to be involved in study due to its relation to long-term
neurodevelopmental effects and altered brain function upon dysfunction. In follow up research,
Ube2D1 showed no difference in basal concentrations for post-mortem schizophrenia patients
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within the dorsolateral prefrontal cortex; however, Ube2D1 was significantly increased in mice
under phencyclidine (PCP) treatment, a model for schizophrenia, at the juvenile time point [37].
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3.5 Characterization of Ube2D2

The least amount is known about Ube2D2 among the three Ube2D family members
analyzed. Perhaps the most important relationship studied for this protein is Ube2D2’s supported
regulation of Parkin in Parkin-dependent mitophagy.
The knockdown of Ube2D2 is correlated with a reduction in the clearing of depolarized
mitochondria with autophagic mechanisms, though the process of PINK1 membrane-embedding
and Parkin translocation remains constant; this may point to redundancy in E2 action.
Knockdown of Ube2D2 with additional E2 knockdowns (Ube2N and Ube2L3) goes further to
decrease Parkin polyubiquitination of the mitochondria and decrease p62 recruitment [38].
Parkin is now thought to exhibit mechanistic features similar to the HECT ubiquitin
ligase family: the RING Ube2D-binding domain is covered and autoinhibited. PINK1
phosphorylation permits the domain release, Ube2D2 can form a thioester bond to Parkin, and
ubiquitination follows. Knockdown of specific E2 partners, therefore, directly relates to
decreased Parkin ubiquitination and subsequent mitophagy [38]. Specifically, Ube2D2 with
Parkin can monoubiquitinate Mfn1 [39].
An identical relationship with Parkin was also linked to Ube2D3 [38].
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3.6 Characterization of Ube2D3

Ube2D3 has been studied with high consideration for tumorigenesis and cancer
progression; it was found to interact with human telomerase reverse transcriptase (hTERT).
hTERT expression usually correlates to telomerase activity and activation, leading to radio
resistance for cancer cell lines, which was countered with Ube2D3 presence. Downregulation of
Ube2D3 resulted in hTERT and cyclin D1 accumulation, cell proliferation, and quicker
transitions from G1 to S phase in human breast cancer cells (MCF-7) [40]. Ube2D3 was also
found to be significantly lower in esophageal cancer lines. The negative correlation linkage
between hTERT and Ube2D3 demonstrated a strong predicting factor for the progression of
human esophageal cancer [41]. Additionally, further study with esophageal squamous carcinoma
cells (EC109) indicated that Ube2D3 overexpression prolonged G1 phase, decreased telomere
length, and enhanced radio sensitivity again through the degradation of hTERT, reiterating the
proposed link found in MCF-7 lines [42]. These results were consistent in Eca-109 cells and it
was further showed that downregulating Ube2D3 led to faster DNA repair after IR exposure
[43]. This data suggests that Ube2D3 manipulation might provide benefits for advancing radio
therapy due to its supported link in cell-cycle control, DNA damage repair, and tumorigenesis
[41]. However, care should be taken after considering the Ube2D family’s abundant involvement
in alternative pathways.
Second, Ube2D3 has been shown to aid in the ubiquitination of RIG-1, which induces the
aggregation of MAVS on mitochondria. This leads to downstream activation of transcription
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factors and initiation of the innate immune response for viral protection through type I interferon
production [44].
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CHAPTER 4: DISCUSSION

The natural mitochondrial cycle involves a continual flow between fission and fusion.
Fission can result in unequal mitochondria sharing and the creation of a depolarized membrane
for one of the daughters [11-13]. This shift from homeostasis creates an increase in
ubiquitination and may lead to mitophagy, a form of autophagy that destroys damaged
mitochondria [20-23]. If the cell cannot manage the excessive damage, the cell may engage in
apoptosis. Mitophagy and apoptosis can lead to disease since an imbalance in mitochondria may
starve cells of energy and lead to neurodegeneration, muscle atrophy and wasting, and
parkinsonian phenotype [26].
Mulan is an E3 ubiquitin ligase that has been implicated in all of these steps towards
disease through interactions with its RING finger domain [1] (Figure 14). Though much research
has been done concerning Mulan’s RING domain, there has been less focus on the full
classification of Mulan’s E2 interactors, their role in a Mulan-derived pathway for mitophagy,
and the potential link to mnd2 mutant mice phenotype. Previously in our lab, a yeast two hybrid
system was used that identified Mulan interactors. In that study, the RING domain of Mulan
(amino acids 259-352) served as bait in a yeast two-hybrid screening and potential interactors
were cloned into pJG4-5. Strong and comparable protein-protein interactions were confirmed to
exist between Mulan and the full-length E2 conjugating enzymes, Ube2E2 and Ube2E3. Since
the yeast two-hybrid system has limitations, an in vitro ubiquitination assay with a recombinant
Mulan-RING domain was used to monitor potential activity with these E2s and any additional
E2 interactors that were not shown in the yeast two-hybrid. This screen identified the same
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interactors, Ube2E2 and Ube2E3, as well as three additional E2s: Ube2D1, Ube2D2, and
Ube2D3. These family members showed considerable promise as strong interactors and potential
partners (Figure 9). All E2’s were cloned into the pJG4-5 vector as full-length proteins and their
interaction with Mulan’s RING domain was tested side by side. They all showed strong positive
interaction with the Mulan bait (Figure 10).
Therefore, we have shown that Ube2D1, Ube2D2, and Ube2D3 are able to interact with
Mulan and work with it in an in vitro ubiquitination assay. This data strongly supports the notion
that these interactions are real, functional and can potentially exist within mammalian cells.
Ube2D1, Ube2D2, and Ube2D3 have been previously studied and are known to be
involved in contending p53-directed apoptosis, neurodegeneration in juvenile mice, possessing
anti-cancer properties, aiding in innate immunity, aiding in the viral lytic cycle, and regulating
the Parkin-dependent mitophagy [31-44]. Though these proteins possess high homology and
some similar roles, their independent functions have a wide variance. This indicates the potential
for different interactions with Mulan.
Since Mulan as an E3 ubiquitin ligase can only interact with one E2 at a time, we
investigated if the tissue distribution or protein level of the various E2s can determine the
identity of the Mulan/E2 combination at any time. Ube2D1, Ube2D2, Ube2D3, and Ube2E3
proteins showed no major differences among each other in their expression levels within the
tissue types. They also displayed great overlap between tissues, indicative of ubiquitous activity.
One result of significance was the high levels of E2 protein expression in the brain, as
opposed to the expression in the heart, kidney, and liver (Figure 12). This directly points to
Mulan having vital functioning with the brain. Dysregulation of Mulan, therefore, might be
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responsible for neurodegeneration and a related loss of function within the brain – neurons are
highly energy demanding, therefore, an increase in mitophagy involving Mulan might be
responsible for phenotype. Since Mulan expression is elevated in mnd2 mutant mice, this data
might also indicate that the dysregulation of Mulan is responsible for the neurodegeneration
apparent in mnd2 mice. A second result showed Ube2D expression was lower in the heart
compared to the liver and kidney samples (Figure 12). This is interesting since Mulan expression
is typically raised in the heart [1,26].
This data does not preclude the option that Mulan initiates its own mitophagy through
collected interactions with other, non-Ube2D interactors. The specific relationship that exists
between Mulan and Parkin is also still unknown and should be studied further; Mulan is thought
to be able to prevent PD phenotype in the absence of PINK1/Parkin, yet its accumulation leads to
PD phenotype in the presence of non-mutated PINK1/Parkin in mice [5,26]. This still points to a
Mulan-dependent mechanism for mitophagy.
The next phase of the project has already been initiated. Further in vitro assays were
performed with Mulan259-352 – E2 protein combinations looking to isolate potential substrates that
interact with each individual ubiquitination complex. Combinations studied include: Mulan +
Ube2D1, Mulan + Ube2D3, and Mulan + Ube2E3. Several potential substrates were identified
for each combination and are being further analyzed.
Future work should focus on quantifying data for E2 expression in varied tissue samples
with qPCR since western blot visualization alone is qualitative. Also, assays should be
performed that involve stressing the cells, isolating the mitochondria and cytoplasm, and
observing if there were changes in E2 expression present between these locations. This would be
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particularly important since the Ube2D proteins are localized within the cytoplasm and must
migrate to interact with mitochondria-bound Mulan. Lastly, it would also be interesting to
conduct temporal studies in accordance with mice development. This could reveal E2
characterization specific to time for growth patterns or Mulan-related disease progression.
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Figure 14: A schematic diagram of the various functions of Mulan and the proteins involved

Mulan E3 Ubiquitin Ligase is known to be involved in mitochondrial dynamics, mitophagy, and
apoptosis. Mulan interacts with Mfn2 and Drp1 to affect fission and fusion; it also activates NFκB, p53, and JNK pathways. Mulan itself is regulated by Omi protease during mitochondrial
stress. Mulan also drives a Parkin-independent pathway to mitophagy. During mitophagy,
Mulan interacts with GABARAP and can compensate for the absence of PINK1 and Parkin. As
an E3 ligase, its activity and substrate specificity are dictated by specific E2 partners.
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